ZZM-1220 is a histone lysine methyltransferase G9a/GLP covalent inhibitor with IC50s of of 458 nM and 924 nM, respectively. ZZM-1220 inhibits H3K9me2 in cells and significantly induces apoptosis of triple-negative breast cancer (TNBC) cells and blocks th
Molecular Weight:
447.53
Purity:
98.74
Formula:
C25H29N5O3
Target:
Apoptosis,Histone Methyltransferase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted